Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Single-center real-world treatment and outcomes in patients with hepatocellular carcinoma receiving immunotherapy.
Authors
Diane Habib
University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA
Diane Habib , Ronak Patel , Sandra Algaze , Syma Iqbal , Victor Yundeh Chiu , Anthony B. El-Khoueiry
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
DOI
10.1200/JCO.2022.40.4_suppl.401
Abstract #
401
Poster Bd #
A10
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Real world data of systemic therapy for hepatocellular carcinoma in Japan: HERITAGE study.
First Author: Yoshinari Asaoka
Poster
2019 Gastrointestinal Cancers Symposium
Outcomes of tyrosine kinase inhibitors (TKI) after immunotherapy in unresectable or advanced hepatocellular carcinoma (HCC) patients.
First Author: Thomas Cheung Yau
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Real-world survival outcomes and treatment patterns in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Results from the OREIOS study.
First Author: Stephen Chan
Poster
2021 Gastrointestinal Cancers Symposium
Posttreatment after lenvatinib in patients with advanced hepatocellular carcinoma.
First Author: Keisuke Koroki